根据PCI后的程序复杂性对血小板反应的预后影响:PTRG-DES联盟的子分析
Xuan Jin1,2, Young-Hoon Jeong3, Kwang Min Lee1
1Department of Cardiology, Dong-A University Hospital, Busan, South Korea.
JACC. Asia
|March 11, 2024
概括
复杂的穿皮冠状动脉干预 (C-PCI) 增加了主要心脏和脑血管不良事件 (MACCE) 的风险,但高血小板反应率 (HPR) 无论程序的复杂性如何,都会带来类似的风险. 高血压是MACCE和一年内死亡的重要预测因素.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 复杂的穿皮冠状动脉干预 (C-PCI) 和高血小板反应率 (HPR) 是已知的缺血事件的危险因素.
- 在接受药物释放支架植入的患者中,C-PCI与HPR的相对预后意义尚不清楚.
研究的目的:
- 调查高血小板反应率 (HPR) 的预后影响,在皮肤穿透冠状动脉干预过程中程序复杂性不同的情况下.
- 确定程序复杂性是否会改变HPR对临床结果的影响.
主要方法:
- 分析了一组11714名接受药物释放支架 (PTRG-PFT队列) 的患者.
- 患者根据程序的复杂性进行了分层. 高血小板反应率 (HPR) 被定义为≥252 P2Y12反应单位.
- 重大心脏和脑血管不良事件 (MACCE) 和大出血被评估至手术后3年.
主要成果:
- 复杂的PCI (C-PCI) 与MACCE的风险增加有关 (调整HR: 1.21),主要是由更高的全因死亡率 (调整HR: 1.45) 推动的.
- 高血小板反应率 (HPR) 与MACCE和全因死亡率有显著的相关性,无论程序的复杂性如何 (P-相互作用值>0.7).
- HPR的预后影响在干预后的第一年内最为明显,在HPR和C-PCI类型之间没有观察到显著的相互作用.
结论:
- 复杂的PCI独立地增加了MACCE和所有原因死亡的3年风险.
- 高血小板反应率 (HPR) 是MACCE和死亡率的显著预后因素,其影响在不同级别的程序复杂性上是一致的.
- 这些发现表明,无论PCI复杂性如何,HPR管理对于具有药物排泄支架的患者至关重要.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
523
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181